Segundo Buján
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
- interferon and immune responses
- Nephrology top 5%
Papers in
-
- Atherosclerosis and Cardiovascular Diseases 3
- IL-33, ST2, and ILC Pathways 2
-
- Systemic Lupus Erythematosus Research 6
- Co-authors
- Jordi Yagüe (3 shared papers)Juan I. Aróstegui (3 shared papers)Pablo Pelegrı́n (2 shared papers)Jordi Antón (1 shared paper)Carlos Martínez (1 shared paper)Isabelle Couillin (1 shared paper)Estíbaliz Ruiz‐Ortiz (1 shared paper)Ana Isabel Gómez Córdoba (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Clinical and Experimental Rheumatology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Lara D. Veeken (1 paper)Nature Immunology (1 paper)
- Partner nations
- SpainUnited KingdomFrance
In The Last Decade
Segundo Buján
10 papers receiving 929 citations
Segundo Buján's Hit Papers
Peers
Comparison fields: 5 of 83
- Immunology 419
- Nephrology 91
- Rheumatology 193
- Biological Psychiatry 29
- Molecular Biology 558
Countries citing papers authored by Segundo Buján
This map shows the geographic impact of Segundo Buján's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Segundo Buján with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Segundo Buján more than expected).
Fields of papers citing papers by Segundo Buján
This network shows the impact of papers produced by Segundo Buján. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Segundo Buján. The network helps show where Segundo Buján may publish in the future.
Co-authors
The 25 scholars most cited alongside Segundo Buján, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response Hit paper breakdown → | 2014 | 640 |
| 2 | 2004 | 73 | |
| 3 | Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. | 2000 | 63 |
| 4 | 2016 | 57 | |
| 5 | 2003 | 46 | |
| 6 | 1997 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 17 | |
| 9 | 2002 | 9 | |
| 10 | 2018 | 1 | |
| 11 | 2014 | 0 | |
| 12 | 2024 | 0 |
About Segundo Buján
Segundo Buján is a scholar working on Immunology, Rheumatology, Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, having authored 12 papers that have together received 945 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (6 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Inflammasome and immune disorders (3 papers), Renal Diseases and Glomerulopathies (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Protein Tyrosine Phosphatases (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Systemic Sclerosis and Related Diseases (1 paper). The work is most often cited by research in Immunology (419 citations), Nephrology (91 citations), Rheumatology (193 citations), Biological Psychiatry (29 citations) and Molecular Biology (558 citations). Segundo Buján has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Jordi Yagüe, Juan I. Aróstegui, Pablo Pelegrı́n, Jordi Antón, Carlos Martínez, Isabelle Couillin, Estíbaliz Ruiz‐Ortiz, Ana Isabel Gómez Córdoba, Alberto Baroja‐Mazo and Fatima Martín‐Sánchez. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Journal of Allergy and Clinical Immunology, Lara D. Veeken and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.